HCmed Innovations Co., Ltd.
Research HCmed Innovations Co., Ltd. (6934.TW) on Bullrun: market cap TWD 3.14B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6934.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyTWD
- Market capTWD 3.14B
- Financial periodQ2 2026
- RevenueTWD 16.13M
- Net income-TWD 45.35M
- Free cash flow-TWD 76.49M
- Gross margin-101.8%
Valuation Snapshot
latest market cap is TWD 3.14B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 3.14B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About HCmed Innovations Co., Ltd.
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells respiratory drug delivery systems in the United States, Europe, Africa, and Asia. The company's products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HCmed Innovations Co., Ltd.'s market cap?
HCmed Innovations Co., Ltd.'s market capitalization is TWD 3.14B.
What does HCmed Innovations Co., Ltd. do?
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells respiratory drug delivery systems in the United States, Europe, Africa, and Asia. The company's products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides intellectual property, advanced technology, customization platforms, manufacturing and commercialization, and APSD analytical services.